✦ LIBER ✦

Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life

✍ Scribed by Schumacher, Andrea; Riesenbeck, Dorothea; Braunheim, Michael; Wewers, Dieter; Heinecke, Achim; Semik, Michael; Hoffknecht, Petra; Macha, Hans N; Klinke, Folker; Schmidt, Ernst-Wilhelm; Willich, Normann; Berdel, Wolfgang E; Thomas, Michael

Book ID: 119318827
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 122 KB
Volume: 44
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2003.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the Epidermal Growth Facto

Inhibition of the Epidermal Growth Factor Receptor in Combined Modality Treatment for Locally Advanced Non-Small Cell Lung Cancer

✍ Neal Ready 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 288 KB

O-307 A two-arm phase I study of OSI-774

O-307 A two-arm phase I study of OSI-774 in combination with chemoradiation for patients with unresectable, locally advanced non-small cell lung cancer

✍ Mauer, Ann M.; Harat, Daniel C.; Rudin, Charles M.; Krauss, Stuart M.; Vokes, Ev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB

2 Quality of life assessment in the elde

2 Quality of life assessment in the elderly population (above 70 years of age) with locally advanced or metastatic non-small cell lung cancer (NSCLC) treated with a platinum-based combination-chemotherapy regimen

✍ Bæksgaard, L.; Henriksen, A.; Hasselbalch, B.; Dandanell, J.; Perell, K.; Sørens 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Quality of life in patients with advance

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study

✍ Chandra P Belani; Thomas Brodowicz; Tudor E Ciuleanu; Maciej Krzakowski; Sung Hy 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 230 KB

Combination Treatment with Weekly Doceta

Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Joan B. Erland; John H. Barton; Dana S. Thompson; M. Patrick 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

P-526 Gemcitabine (G) or vinorelbine (V)

P-526 Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinum-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A 6 years retrospective study

✍ Barradas, Pedro S.; Melo, Maria Jose S.; Cristovao, Margarida M.; Costa, Agostin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB